QR-koda

Effectiveness and safety of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer with increasing incidence. The anti-PD-1 therapy cemiplimab has shown its antitumor activity in locally advanced (lacSCC) and metastatic cSCC (mcSCC). This retrospective study assessed the real-life effectiveness and safety of cemiplim...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Gabriele Roccuzzo, Eleonora Bongiovanni, Giovanni Actis-Giorgetto, Chiara Astrua, Matteo Giovanni Brizio, Giovanni Cavaliere, Paolo Fava, Simone Ribero, Pietro Quaglino
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Frontiers Media S.A. 2026-03-01
Ráidu:Frontiers in Pharmacology
Fáttát:
cemiplimab
checkpoint inhibitor therapy
cutaneous squamous cell carcinoma
immunosuppression
PD-1 inhibitors
real-life
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fphar.2026.1601650/full
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid